Abstract
The risk of venous thromboembolism (VTE) may be increased in patients with liver diseases. A systematic review and meta-analysis were conducted to analyze the epidemiology of VTE in such patients. All relevant studies were searched via the PubMed, EMBASE, and Cochrane Library databases. The incidence and prevalence of VTE were pooled using random-effect models. Subgroup analyses were conducted according to the type of VTE [deep vein thrombosis (DVT), pulmonary embolism (PE)], type of liver disease (liver cirrhosis alone/unclassified liver diseases or non-cirrhotics), region in which the study was performed (USA/Europe/Asia), number of total observed patients with liver diseases (>1,000/<1,000 patients), study quality (high/low), and methods for identifying the cases (ICD codes/clinical charts). Of 4,843 papers initially identified, 20 were included. The incidence of VTE varied from 0.33 to 6.32 % in 14 studies with a pooled value of 1 % (95 % confidence interval (CI) 0.7–1.3 %). The pooled incidence of DVT and PE was 0.6 % (95 % CI 0.4–0.8 %) and 0.28 % (95 % CI 0.13–0.49 %), respectively. The prevalence of VTE varied from 0.6 to 4.69 % in six studies with a pooled value of 1.0 % (95 % CI 0.7–1.2 %). The pooled prevalence of DVT and PE was 0.7 % (95 % CI 0.6–0.9 %) and 0.36 % (95 % CI 0.13–0.7 %), respectively. The heterogeneity was statistically significant in the main and subgroup meta-analyses. In conclusion, about 1 % of patients with liver diseases develop or are diagnosed with VTE during their hospitalizations. However, the epidemiological data are very heterogeneous among studies.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- VTE:
-
Venous thromboembolism
- DVT:
-
Deep vein thrombosis
- PE:
-
Pulmonary embolism
References
Tripodi A, Mannucci PM (2011) The coagulopathy of chronic liver disease. N Engl J Med 365:147–156
Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT et al (2010) Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 53:362–371
Northup PG, Caldwell SH (2013) Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol 11:1064–1074
Amitrano L, Guardascione MA, Brancaccio V, Balzano A (2002) Coagulation disorders in liver disease. Semin Liver Dis 22:83–96
Sogaard KK, Horvath-Puho E, Gronbaek H, Jepsen P, Vilstrup H, Sorensen HT (2009) Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 104:96–101
Wu H, Nguyen GC (2010) Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol 8:800–805
Tripodi A, Primignani M, Chantarangkul V, Dell’Era A, Clerici M, de Franchis R et al (2009) An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 137:2105–2111
Tripodi A, Primignani M, Lemma L, Chantarangkul V, Mannucci PM (2013) Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis. J Hepatol 59:265–270
Tripodi A, Anstee QM, Sogaard KK, Primignani M, Valla DC (2011) Hypercoagulability in cirrhosis: causes and consequences. J Thromb Haemost 9:1713–1723
Dabbagh O, Oza A, Prakash S, Sunna R, Saettele TM (2010) Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest 137:1145–1149
Northup PG, McMahon MM, Ruhl AP, Altschuler SE, Volk-Bednarz A, Caldwell SH et al (2006) Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 101:1524–1528 quiz 1680
Gopal K, Broder A, Benias P, Min AD (2010) Practice patterns among medicine housestaff in prevention of venous thromboembolism among hospitalized patients with end-stage liver disease. Gastroenterology 138:S457
Goldhaber SZ, Bounameaux H (2012) Pulmonary embolism and deep vein thrombosis. Lancet 379:1835–1846
Garcia-Fuster MJ, Abdilla N, Fabia MJ, Fernandez C, Oliver V (2008) Forner MJ [Venous thromboembolism and liver cirrhosis]. Rev Esp Enferm Dig 100:259–262
Ali M, Ananthakrishnan AN, McGinley EL, Saeian K (2011) Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci 56:2152–2159
Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S (2008) Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci 53:3012–3017
Lesmana CR, Inggriani S, Cahyadinata L, Lesmana LA (2010) Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int 4:433–438
Saleh T, Matta F, Alali F, Stein PD (2011) Venous thromboembolism with chronic liver disease. Am J Med 124:64–68
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012
Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D’Andrea G et al (2000) Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 31:345–348
Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F et al (2009) Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 51:682–689
Ahmed S, Mehta V, Vendetti N, Ann Phang K, Su Y, Kim H et al (2012) Risk of venous thromboembolism (VTE) in patients with chronic hepatitis C (CHC. Pharmacoepidemiol Drug Saf 21:94
Aldawood A, Arabi Y, Aljumah A, Alsaadi A, Rishu A, Aldorzi H et al (2011) The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J 9:1
Al-Dorzi HM, Bhat S, Tamim H, Khokar S, Hussain S, Al-Dawood A et al (2010) Practices of venous thromboembolism prophylaxis and incidence in critically ill cirrhotic patients. Am J Respir Crit Care Med 181
Anthony Lizarraga W, Dalia S, Reinert SE, Schiffman FJ (2010) Venous thrombosis in patients with chronic liver disease. Blood Coagul Fibrinolysis 21:431–435
Barclay SM, Jeffres MN, Nguyen K, Nguyen T (2013) Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease. Pharmacotherapy 33:375–382
Girleanu I, Trifan A, Cojocariu C, Singeap AM, Sfarti C, Stanciu C (2012) The risk of thrombotic events in patients with liver cirrhosis. Rev Med Chir Soc Med Nat Iasi 116:991–996
Kohsaka S, Nagai T, Yaegashi M, Fukuda K (2012) Pulmonary embolism and deep venous thrombosis in hospitalized patients with liver cirrhosis. Hepatology Research 42:433–434
Kumar G, Kumar N, Deshmukh A, Sakhuja A, Taneja A, Padala K et al (2010) Is cirrhosis protective for venous thromboembolism? Analysis from a national inpatient sample. Chest 138
Ponziani FR, Zocco MA, Garcovich M, Roccarina D, Gasbarrini A (2013) Epidemiology of venous thrombotic events and pulmonary embolism among hospitalized cirrhotic patients: a single center experience. Digestive and Liver Disease 45:S41
Shah NL, Northup PG, Caldwell SH (2012) A clinical survey of bleeding, thrombosis, and blood product use in decompensated cirrhosis patients. Ann Hepatol 11:686–690
Smith CB, Hurdle AC, Kemp LO, Sands C, Twilla JD (2013) Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease. J Hosp Med 8:569–573
Walsh KA, Lewis DA, Clifford TM, Hundley JC, Gokun Y, Angulo P et al (2013) Risk factors for venous thromboembolism in patients with chronic liver disease. Ann Pharmacother 47:333–339
Algahtani FH, Bayoumi N, Abdelgadir A, Al-Nakshabandi N, Al Aseri Z, Al Ghamdi M et al (2013) Clinical characteristics and risk factors of pulmonary embolism: data from a Saudi tertiary-care center. J Thromb and Haemost 11:388–390
Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA (2007) Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 167:935–943
Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ (2011) Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Medicine 9
Ocak G, Vossen CY, Verduijn M, Dekker FW, Rosendaal FR, Cannegieter SC et al (2013) Risk of venous thrombosis in patients with major illnesses: results from the MEGA study. J Thromb Haemost 11:116–123
Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160:809–815
Shaheen AAM, Tanyingoh D, Dixon E, Kaplan GG, Myers RP (2012) Medical injuries among hospitalized patients with cirrhosis: a population-based study. Hepatology 56:1083A–1084A
Ford AC, Marwaha A, Lim A, Moayyedi P (2010) What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol 8:830–837 837 e831–832
Ford AC, Marwaha A, Lim A, Moayyedi P (2010) Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol 8:401–409
Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H et al (2013) Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology 58:1215–1224
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Qi, X., Ren, W., Guo, X. et al. Epidemiology of venous thromboembolism in patients with liver diseases: a systematic review and meta-analysis. Intern Emerg Med 10, 205–217 (2015). https://doi.org/10.1007/s11739-014-1163-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-014-1163-7